We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Safety Will Improve Under FDA's Critical Path Initiative
Drug Safety Will Improve Under FDA's Critical Path Initiative
April 29, 2005
Recent drug safety concerns will be addressed in the FDA’s Critical Path Initiative, which aims to bring more efficiency to the drug development process, according to a top FDA official.